Globally, antibiotic consumption increased 16.3% from 2016 to 2023 and is projected to continue increasing through 2030.
Higher cumulative defined daily doses of statins correlate with improved survival outcomes, particularly with rosuvastatin and atorvastatin. Statins have demonstrated potential anticancer effects ...